| abstract |
The present invention relates to novel 5-sulfonyl-amino-5,6-dihydro -1 H having an inhibitory activity on one of the 5-HT 6 serotonin subtypes of the pyrazolo [3,4- c] pyridin-7 (4 H ) -one compound and a pharmaceutical composition comprising the compound as an active ingredient. The novel compounds of the present invention have 5-HT 6 inhibitory activity and thus can be used for the treatment of central nervous system such as Alzheimer's (AD), attention deficit disorder (ADHD), epilepsy, depression, obesity, schizophrenia, central nervous system) diseases, for the purpose of diagnosis, prevention and treatment. |